Qube Research & Technologies (QRT)
ORMP icon

Qube Research & Technologies (QRT)’s Oramed Pharmaceuticals ORMP Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23,504
Closed -$79.9K – 3905
2026
Q1 		$79.9K Buy
+23,504
New +$79.7K ﹤0.01% 3105
2024
Q3 		– Sell
-107
Closed -$275 – 3893
2024
Q2 		$275 Sell
107
-88,089
-100% -$209K ﹤0.01% 3366
2024
Q1 		$258K Buy
88,196
+1,676
+2% +$4.69K ﹤0.01% 2900
2023
Q4 		$200K Buy
86,520
+76,630
+775% +$164K ﹤0.01% 2788
2023
Q3 		$25.8K Buy
+9,890
New +$31.1K ﹤0.01% 3070
2023
Q2 		– Sell
-31,309
Closed -$68.3K – 2829
2023
Q1 		$68.3K Sell
31,309
-11,522
-27% -$36.6K ﹤0.01% 2185
2022
Q4 		$515K Buy
42,831
+14,036
+49% +$109K ﹤0.01% 1459
2022
Q3 		$187K Sell
28,795
-24,333
-46% -$197K ﹤0.01% 1796
2022
Q2 		$243K Sell
53,128
-3,220
-6% -$17.2K ﹤0.01% 1655
2022
Q1 		$487K Sell
56,348
-8,451
-13% -$86.6K ﹤0.01% 1543
2021
Q4 		$925K Buy
+64,799
New +$1.35M 0.01% 1239
2021
Q3 		– Sell
-16,407
Closed -$220K – 2627
2021
Q2 		$220K Buy
+16,407
New +$188K ﹤0.01% 1747
2021
Q1 		– Sell
-54,291
Closed -$230K – 2280
2020
Q4 		$230K Sell
54,291
-21,104
-28% -$68.7K ﹤0.01% 1481
2020
Q3 		$197K Buy
75,395
+59,204
+366% +$206K ﹤0.01% 1401
2020
Q2 		$57K Buy
+16,191
New +$54.3K ﹤0.01% 1587

Other funds holding ORMP

Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $163M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ORMP Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Oramed Pharmaceuticals (ORMP) in Q2 2026, closing a stake of 23,504 shares — an estimated $79.9K sold.

Qube Research & Technologies (QRT) first reported a position in ORMP in Q2 2020 and held it in 15 quarters. The position peaked at $925K in Q4 2021. 84 funds tracked by Wall St. Rank hold ORMP as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Oramed Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 23,504 Oramed Pharmaceuticals shares in Q2 2026, an estimated $79.9K.
  • Qube Research & Technologies (QRT) first reported a position in Oramed Pharmaceuticals in Q2 2020 and held it in 15 quarters.
  • Qube Research & Technologies (QRT)'s Oramed Pharmaceuticals position peaked at $925K in Q4 2021.
  • 84 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.